The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Lysosome‐associated membrane protein 1 (LAMP‐1) in Alzheimer’s disease
Abstract
Lysosome‐associated membrane protein 1 (LAMP‐1) is a glycoprotein highly expressed in lysosomal membranes. The present study was initiated to test LAMP‐1 mRNA and protein levels in post mortem frontal cortex (area 8) of Alzheimer’s disease (AD) stages I–IIA/B and stages V–VIC of Braak and Braak, compared with age‐matched controls. TaqMan PCR assays and Western blots demonstrated upregulation of LAMP‐1 mRNA and protein in the cerebral cortex in ADVC. In addition, immunohistochemical studies have shown increased LAMP‐1 immunoreactivity in neurones, and in glial cells surrounding senile plaques, in AD cases. Interestingly, LAMP‐1 immunoreactivity has little correlation with phosphorylated tau deposition and neurofibrillary tangles (NFTs), as neurones with NFTs were rarely LAMP‐1 immunoreactive. In contrast, LAMP‐1 expression was enhanced in neurones with granulovacuolar degeneration. Finally, LAMP‐1 occurred in microglia and multinucleated giant cells in one AD case in whom amyloid burden was cleared following βA‐peptide immunization. These findings support the participation of lysosomes in βA‐amyloid and, probably, in hyperphosphorylated tau turnover in AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
LAMP1 is mislocalized to dystrophic neurites in 5XFAD models and in human Alzheimer's disease.
“membrane protein 1 (LAMP1) is mislocalized to dystrophic neurites in 5XFAD models (Forner et al., 2021;Gowrishankar et al., 2015;Wickline et al., 2023) and human AD (Barrachina et al., 2006).”
From Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease (2024) · cites this paper as Barrachina et al., 2006
Citations
Cites
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Cataldo, A. M., Barnett, J. L., Pieroni, C., & Nixon, R. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-16-06142.1997 · Cited by 393
Cataldo, A. M., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., & Nixon, R. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90324-0 · Cited by 379
Carlsson, S. R., Roth, J., Piller, F., & Fukuda, M. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)37369-1 · Cited by 345
Flagged first, then by citations
Research works printed but not linked: 16
- Duyckaerts C, 2003, Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders., 47
- 10.1023/A:1007675508413 · DOI
- 10.1073/pnas.88.24.10998 · DOI
- 10.1097/00005072-199606000-00004 · DOI
- 10.1093/jnen/63.8.821 · DOI
- 10.1006/exnr.1999.7087 · DOI
- 10.1046/j.1471-4159.2000.0741469.x · DOI
- 10.1006/mcne.2001.1051 · DOI
- 10.1016/S0021-9258(19)38504-7 · DOI
- 10.1007/978-1-4615-4885-0_14 · DOI
- 10.1111/j.1750-3639.2004.tb00493.x · DOI · Paper page
- 10.1212/01.WNL.0000148590.39911.DF · DOI
- 10.1097/00005072-196701000-00003 · DOI
- Wisniewski HM, 1973, Progress in Neuropathology, 1
- 10.1046/j.1471-4159.1997.69052026.x · DOI
- 10.1074/jbc.M108161200 · DOI · Paper page
Cited by
Sorted by citations
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
Zhang, P., Kishimoto, Y., Grammatikakis, I., Gottimukkala, K., Cutler, R. G., Zhang, S., Abdelmohsen, K., Bohr, V. A., Misra Sen, J., Gorospe, M., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0372-9 · Cited by 977
Dickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29715 · Cited by 642
Gowrishankar, S., Yuan, P., Wu, Y., Schrag, M., Paradise, S., Grutzendler, J., De Camilli, P., & Ferguson, S. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510329112 · Cited by 406
Piras, A., Collin, L., Grüninger, F., Graff, C., & Rönnbäck, A. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0292-9 · Cited by 271
Cerebrospinal fluid biomarkers in Parkinson disease
Parnetti, L., Castrioto, A., Chiasserini, D., Persichetti, E., Tambasco, N., El-Agnaf, O., & Calabresi, P. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.10 · Cited by 209
Ferrer, I. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.03.005 · Cited by 174
Self-citationAnnunziata, I., Patterson, A., Helton, D., Hu, H., Moshiach, S., Gomero, E., Nixon, R., & d’Azzo, A. (2013) · Nature Communications · doi:10.1038/ncomms3734 · Cited by 146
Aducanumab anti-amyloid immunotherapy induces sustained microglial and immune alterations
Cadiz, M. P., Gibson, K. A., Todd, K. T., Nascari, D. G., Massa, N., Lilley, M. T., Olney, K. C., Al-Amin, M. M., Jiang, H., Holtzman, D. M., et al. (2024) · Journal of Experimental Medicine · doi:10.1084/jem.20231363 · Cited by 55
The Alzheimer's Disease Gene SORL1 Regulates Lysosome Function in Human Microglia
Mishra, S., Morshed, N., Sidhu, S. B., Kinoshita, C., Stevens, B., Jayadev, S., & Young, J. E. (2025) · Glia · doi:10.1002/glia.70009 · Cited by 31
Martá-Ariza, M., Leitner, D. F., Kanshin, E., Suazo, J., Giusti Pedrosa, A., Thierry, M., Lee, E. B., Devinsky, O., Drummond, E., Fortea, J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02844-z · Cited by 15
Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease
Odfalk, K. F., Wickline, J. L., Smith, S., Dobrowolski, R., & Hopp, S. C. (2024) · Hippocampus · doi:10.1002/hipo.23586 · Cited by 2
Metadata
- Authors
- Barrachina, M., Maes, T., Buesa, C., & Ferrer, I.
- Venue
- Neuropathology and Applied Neurobiology
- Publisher
- Wiley
- Published
- 2006-09-15
- Volume
- 32
- Issue
- 5
- Pages
- 505-516
- ISSN
- 0305-1846
- 1365-2990
- Cited by
- 83
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review